<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="17/11/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9343406" creator="Yo Shidahara">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9343406</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Blockade of <term sem="Other" id="T1" lex="T-cell_activation"><term sem="Cell_natural" id="A1">T-cell</term> activation</term> by <term sem="Organic_compound_other" id="T2" lex="dithiocarbamate">dithiocarbamates</term> involves novel mechanisms of inhibition of <term sem="Protein_family_or_group" id="T3" lex="nuclear_factor_of_activated_T_cells">nuclear factor of activated T cells</term>.</sentence>
<event id="E1">
<type class="Physiological_process" />
<theme idref="A1" />
<clue>Blockade of T-cell <clueType>activation</clueType> by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E1" />
<cause idref="T2" />
<clue><clueType>Blockade</clueType> <linkTheme>of</linkTheme> T-cell activation <linkCause>by</linkCause> dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.</clue>
</event>
<event id="E3">
<type class="Negative_regulation" />
<theme idref="T3" />
<clue>Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of <clueType>inhibition</clueType> <linkTheme>of</linkTheme> nuclear factor of activated T cells.</clue>
</event>
<event id="E4">
<type class="Correlation" />
<theme idref="E2" />
<theme idref="E3" />
<clue>Blockade of T-cell activation by dithiocarbamates <clueType>involves</clueType> novel mechanisms of inhibition of nuclear factor of activated T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Organic_compound_other" id="T4" lex="dithiocarbamate">Dithiocarbamates</term> (<term sem="Organic_compound_other" id="T5" lex="DTC">DTCs</term>) have recently been reported as powerful inhibitors of <term sem="Other" id="T6" lex="NF-kappaB_activation"><term sem="Protein_complex" id="T7" lex="NF-kappaB">NF-kappaB</term> activation</term> in a number of cell types.</sentence>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="T7" />
<clue>Dithiocarbamates (DTCs) have recently been reported as powerful inhibitors of NF-kappaB <clueType>activation</clueType> in a number of cell types.</clue>
</event>
<event id="E6">
<type class="Negative_regulation" />
<theme idref="E5" />
<cause idref="T5" />
<clue>Dithiocarbamates (DTCs) have recently been reported as powerful <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> NF-kappaB activation <clueLoc>in a number of cell types</clueLoc>.</clue>
</event>
<sentence id="S3">Given the role of this transcription factor in the regulation of <term sem="Other" id="T8" lex="gene_expression">gene expression</term> in the <term sem="Other" id="T9" lex="inflammatory_response">inflammatory response</term>, <term sem="Organic_compound_other" id="T10" lex="NF-kappaB_inhibitor"><term sem="Protein_complex" id="T11" lex="NF-kappaB">NF-kappaB</term> inhibitors</term> have been suggested as potential <term sem="Organic_compound_other" id="T12" lex="therapeutic_drug">therapeutic drugs</term> for <term sem="Other" id="T13" lex="inflammatory_disease">inflammatory diseases</term>.</sentence>
<event id="E7">
<type class="Regulation" />
<theme idref="T8" />
<clue>Given the role of this transcription factor in the <clueType>regulation</clueType> <linkTheme>of</linkTheme> gene expression <clueTime>in the inflammatory response</clueTime>, NF-kappaB inhibitors have been suggested as potential therapeutic drugs for inflammatory diseases.</clue>
</event>
<event id="E8">
<type class="Regulation" />
<theme idref="E7" />
<cause idref="T7" />
<clue>Given the <clueType>role</clueType> <linkCause>of</linkCause> <corefCause>this transcription factor</corefCause> <linkTheme>in</linkTheme> the regulation of gene expression in the inflammatory response, NF-kappaB inhibitors have been suggested as potential therapeutic drugs for inflammatory diseases.</clue>
</event>
<event id="E9">
<type class="Negative_regulation" />
<theme idref="T11" />
<clue>Given the role of this transcription factor in the regulation of gene expression in the inflammatory response, NF-kappaB <clueType>inhibitors</clueType> have been suggested as potential therapeutic drugs for inflammatory diseases.</clue>
</event>
<sentence id="S4">We show here that <term sem="Organic_compound_other" id="T14" lex="DTC">DTCs</term> inhibited both <term sem="Other" id="T15" lex="interleukin_2_(IL-2)_synthesis"><term sem="Protein_molecule" id="T16" lex="interleukin_2">interleukin 2</term> (<term sem="Protein_molecule" id="T17" lex="IL-2">IL-2</term>) synthesis</term> and membrane expression of <term sem="Protein_family_or_group" id="T18" lex="antigen">antigens</term> which are induced during <term sem="Other" id="T19" lex="T-cell_activation"><term sem="Cell_natural" id="A2">T-cell</term> activation</term>.</sentence>
<event id="E10">
<type class="Gene_expression" />
<theme idref="T17" />
<clue>We show here that DTCs inhibited both interleukin 2 (IL-2) <clueType>synthesis</clueType> and membrane expression of antigens which are induced during T-cell activation.</clue>
</event>
<event id="E11">
<type class="Gene_expression" />
<theme idref="T18" />
<clue>We show here that DTCs inhibited both interleukin 2 (IL-2) synthesis and <clueLoc>membrane</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> antigens which are induced during T-cell activation.</clue>
<comment>ERROR &quot;THEME is not T19 but T18&quot;</comment>
</event>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="T19" />
<clue>We show here that DTCs inhibited both interleukin 2 (IL-2) synthesis and membrane expression of antigens which are <clueType>induced</clueType> <clueTime>during T-cell activation</clueTime>.</clue>
</event>
<event id="E13">
<type class="Negative_regulation" />
<theme idref="E10" />
<cause idref="T14" />
<clue>We show here that DTCs <clueType>inhibited</clueType> both interleukin 2 (IL-2) synthesis and membrane expression of antigens which are induced during T-cell activation.</clue>
</event>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="E11" />
<cause idref="T14" />
<clue>We show here that DTCs <clueType>inhibited</clueType> both interleukin 2 (IL-2) synthesis and membrane expression of antigens which are induced during T-cell activation.</clue>
</event>
<event id="E15">
<type class="Physiological_process" />
<theme idref="A2" />
<clue>We show here that DTCs inhibited both interleukin 2 (IL-2) synthesis and membrane expression of antigens which are induced during T-cell <clueType>activation</clueType>.</clue>
</event>
<sentence id="S5">This inhibition, which occurred with a parallel activation of <term sem="Other" id="T20" lex="c-Jun_transactivating_function"><term sem="Protein_molecule" id="T21" lex="c-Jun">c-Jun</term> transactivating functions</term> and expression, was reflected by <term sem="Other" id="T22" lex="transfection_experiment">transfection experiments</term> at the <term sem="Other" id="T23" lex="IL-2_promoter_level"><term sem="DNA_domain_or_region" id="T24" lex="IL-2_promoter"><term sem="Protein_molecule" id="T25" lex="IL-2">IL-2</term> promoter</term> level</term>, and involved not only the inhibition of <term sem="Other" id="T26" lex="NF-kappaB-driven_reporter_activation"><term sem="Protein_complex" id="T27" lex="NF-kappaB">NF-kappaB</term>-driven <term sem="DNA_domain_or_region" id="A3">reporter</term> activation</term> but also that of <term sem="Protein_family_or_group" id="T28" lex="nuclear_factor_of_activated_T_cells">nuclear factor of activated T cells</term> (<term sem="Protein_family_or_group" id="T29" lex="NFAT">NFAT</term>).</sentence>
<event id="E16">
<type class="Positive_regulation" />
<cause idref="T21" />
<clue>This inhibition, which occurred with a parallel activation of c-Jun <clueType>transactivating functions</clueType> and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E17">
<type class="Gene_expression" />
<theme idref="T21" />
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and <clueType>expression</clueType>, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E18">
<type class="Positive_regulation" />
<theme idref="E16" />
<clue>This inhibition, which occurred with a parallel <clueType>activation</clueType> <linkTheme>of</linkTheme> c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="E17" />
<clue>This inhibition, which occurred with a parallel <clueType>activation</clueType> <linkTheme>of</linkTheme> c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E20">
<type class="Correlation" />
<theme idref="E13" />
<theme idref="E18" />
<clue><corefTheme>This inhibition</corefTheme>, which <clueType>occurred</clueType> <linkTheme>with</linkTheme> a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E21">
<type class="Correlation" />
<theme idref="E13" />
<theme idref="E19" />
<clue><corefTheme>This inhibition</corefTheme>, which <clueType>occurred</clueType> <linkTheme>with</linkTheme> a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E22">
<type class="Correlation" />
<theme idref="E14" />
<theme idref="E18" />
<clue><corefTheme>This inhibition</corefTheme>, which <clueType>occurred</clueType> <linkTheme>with</linkTheme> a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E23">
<type class="Correlation" />
<theme idref="E14" />
<theme idref="E19" />
<clue><corefTheme>This inhibition</corefTheme>, which <clueType>occurred</clueType> <linkTheme>with</linkTheme> a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E24">
<type class="Positive_regulation" />
<theme idref="A3" />
<cause idref="T27" />
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-<linkCause>driven</linkCause> reporter <clueType>activation</clueType> but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E24" />
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E26">
<type class="Negative_regulation" />
<theme idref="T29" />
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also <clueType>that</clueType> <linkTheme>of</linkTheme> nuclear factor of activated T cells (NFAT).</clue>
<comment>CAUTION: that=inhibition</comment>
</event>
<event id="E27">
<type class="Correlation" />
<theme idref="E13" />
<theme idref="E25" />
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and <clueType>involved</clueType> not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E28">
<type class="Correlation" />
<theme idref="E13" />
<theme idref="E26" />
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and <clueType>involved</clueType> not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E29">
<type class="Correlation" />
<theme idref="E14" />
<theme idref="E25" />
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and <clueType>involved</clueType> not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E30">
<type class="Correlation" />
<theme idref="E14" />
<theme idref="E26" />
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and <clueType>involved</clueType> not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<sentence id="S6">Accordingly, <term sem="Other" id="T30" lex="electrophoretic_mobility_shift_assay">electrophoretic mobility shift assays</term> (<term sem="Other" id="T31" lex="EMSA">EMSAs</term>) indicated that <term sem="Organic_compound_other" id="T32" lex="pyrrolidine_DTC">pyrrolidine DTC</term> (<term sem="Organic_compound_other" id="T33" lex="PDTC">PDTC</term>) prevented <term sem="Protein_complex" id="T34" lex="NF-kappaB">NF-kappaB</term>, and <term sem="Other" id="T35" lex="NFAT_DNA-binding_activity"><term sem="Protein_family_or_group" id="T36" lex="NFAT">NFAT</term> <term sem="DNA_domain_or_region" id="A4">DNA</term>-binding activity</term> in <term sem="Cell_natural" id="T37" lex="T_cell">T cells</term> stimulated with either <term sem="Organic_compound_other" id="T38" lex="phorbol_myristate_acetate">phorbol myristate acetate</term> plus <term sem="Organic_compound_other" id="T39" lex="ionophore">ionophore</term> or <term sem="Protein_family_or_group" id="A16">antibodies against the <term sem="Protein_complex" id="T40" lex="CD3-T-cell_receptor_complex">CD3-T-cell receptor complex</term></term> and simultaneously activated the binding of <term sem="Protein_molecule" id="T41" lex="AP-1">AP-1</term>.</sentence>
<event id="E31">
<type class="Binding" />
<theme idref="T34" />
<theme idref="A4" />
<clue>Accordingly, electrophoretic mobility shift assays (EMSAs) indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-<clueType>binding activity</clueType> in T cells stimulated with either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
</event>
<event id="E32">
<type class="Binding" />
<theme idref="T36" />
<theme idref="A4" />
<clue>Accordingly, electrophoretic mobility shift assays (EMSAs) indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-<clueType>binding activity</clueType> in T cells stimulated with either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
</event>
<event id="E33">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="T33" />
<clue>Accordingly, <clueExperiment>electrophoretic mobility shift assays (EMSAs)</clueExperiment> indicated that pyrrolidine DTC (PDTC) <clueType>prevented</clueType> NF-kappaB, and NFAT DNA-binding activity <clueLoc>in T cells stimulated with either phorbol myristate acetate plus ionophore</clueLoc> or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
</event>
<event id="E133">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="T33" />
<clue>Accordingly, <clueExperiment>electrophoretic mobility shift assays (EMSAs)</clueExperiment> indicated that pyrrolidine DTC (PDTC) <clueType>prevented</clueType> NF-kappaB, and NFAT DNA-binding activity i<clueLoc>n T cells stimulated with</clueLoc> either phorbol myristate acetate plus ionophore or <clueLoc>antibodies against the CD3-T-cell receptor complex</clueLoc> and simultaneously activated the binding of AP-1.</clue>
</event>
<event id="E34">
<type class="Negative_regulation" />
<theme idref="E32" />
<cause idref="T33" />
<clue>Accordingly, <clueExperiment>electrophoretic mobility shift assays (EMSAs)</clueExperiment> indicated that pyrrolidine DTC (PDTC) <clueType>prevented</clueType> NF-kappaB, and NFAT DNA-binding activity <clueLoc>in T cells stimulated with either phorbol myristate acetate plus ionophore</clueLoc> or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
</event>
<event id="E134">
<type class="Negative_regulation" />
<theme idref="E32" />
<cause idref="T33" />
<clue>Accordingly, <clueExperiment>electrophoretic mobility shift assays (EMSAs)</clueExperiment> indicated that pyrrolidine DTC (PDTC) <clueType>prevented</clueType> NF-kappaB, and NFAT DNA-binding activity <clueLoc>in T cells stimulated with</clueLoc> either phorbol myristate acetate plus ionophore or <clueLoc>antibodies against the CD3-T-cell receptor complex</clueLoc> and simultaneously activated the binding of AP-1.</clue>
</event>
<event id="E35">
<type class="Physiological_process" />
<theme idref="T37" />
<cause idref="T38" />
<cause idref="T39" />
<clue>Accordingly, electrophoretic mobility shift assays (EMSAs) indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-binding activity in T cells <clueType>stimulated</clueType> <linkCause>with</linkCause> either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
</event>
<event id="E36">
<type class="Physiological_process" />
<theme idref="T37" />
<cause idref="A16" />
<clue>Accordingly, electrophoretic mobility shift assays (EMSAs) indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-binding activity in T cells <clueType>stimulated</clueType> <linkCause>with</linkCause> either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
<comment>TPS A16</comment>
</event>
<event id="E37">
<type class="Binding" />
<theme idref="T41" />
<theme idref="A4" />
<clue>Accordingly, electrophoretic mobility shift assays (EMSAs) indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-binding activity in T cells stimulated with either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously activated the <clueType>binding</clueType> <linkTheme>of</linkTheme> AP-1.</clue>
</event>
<event id="E38">
<type class="Positive_regulation" />
<theme idref="E37" />
<cause idref="T33" />
<clue>Accordingly, <clueExperiment>electrophoretic mobility shift assays (EMSAs)</clueExperiment> indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-binding activity in T cells stimulated with either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously <clueType>activated</clueType> the binding of AP-1.</clue>
</event>
<sentence id="S7">Furthermore, <term sem="Organic_compound_other" id="T42" lex="PDTC">PDTC</term> differentially targeted both <cons sem="(AND Protein_family_or_group Protein_family_or_group)" id="T43" lex="(AND NFATp_family_member NFATc_family_member)"><frag id="F1"><term sem="Protein_family_or_group" id="A6">NFATp</term></frag> and <frag id="F2"><term sem="Protein_family_or_group" id="A7">NFATc</term></frag> <frag id="F3"><term sem="Protein_family_or_group" id="A8">family members</term></frag></cons>, inhibiting the transactivation functions of <term sem="Protein_family_or_group" id="T44" lex="NFATp">NFATp</term> and <term sem="Other" id="T45" lex="mRNA_induction">mRNA induction</term> of <term sem="Protein_family_or_group" id="T46" lex="NFATc">NFATc</term>.</sentence>
<event id="E39">
<type class="Regulation" />
<theme idref1="A8" idref="A6" />
<cause idref="T42" />
<clue>Furthermore, PDTC differentially <clueType>targeted</clueType> both NFATp and NFATc family members, inhibiting the transactivation functions of NFATp and mRNA induction of NFATc.</clue>
</event>
<event id="E40">
<type class="Regulation" />
<theme idref1="A8" idref="A7" />
<cause idref="T42" />
<clue>Furthermore, PDTC differentially <clueType>targeted</clueType> both NFATp and NFATc family members, inhibiting the transactivation functions of NFATp and mRNA induction of NFATc.</clue>
</event>
<event id="E41">
<type class="Positive_regulation" />
<cause idref="T44" />
<clue>Furthermore, PDTC differentially targeted both NFATp and NFATc family members, inhibiting the <clueType>transactivation functions</clueType> <linkCause>of</linkCause> NFATp and mRNA induction of NFATc.</clue>
</event>
<event id="E141">
<type class="Transcription" />
<theme idref="T46" />
<clue>Furthermore, PDTC differentially targeted both NFATp and NFATc family members, inhibiting the transactivation functions of NFATp and <clueType>mRNA induction</clueType> <linkTheme>of</linkTheme> NFATc.</clue>
</event>
<event id="E42">
<type class="Negative_regulation" />
<theme idref="E40" />
<cause idref="T42" />
<clue>Furthermore, PDTC differentially targeted both NFATp and NFATc family members, <clueType>inhibiting</clueType> the transactivation functions of NFATp and mRNA induction of NFATc.</clue>
</event>
<event id="E43">
<type class="Negative_regulation" />
<theme idref="E141" />
<cause idref="T42" />
<clue>Furthermore, PDTC differentially targeted both NFATp and NFATc family members, <clueType>inhibiting</clueType> the transactivation functions of NFATp and mRNA induction of NFATc.</clue>
</event>
<sentence id="S8">Strikingly, <term sem="Other" id="T47" lex="Western_blotting">Western blotting</term> and <term sem="Other" id="T48" lex="immunocytochemical_experiment">immunocytochemical experiments</term> indicated that <term sem="Organic_compound_other" id="T49" lex="PDTC">PDTC</term> promoted a transient and rapid shuttling of <term sem="Protein_family_or_group" id="T50" lex="NFATp">NFATp</term> and <term sem="Protein_family_or_group" id="T51" lex="NFATc">NFATc</term>, leading to their accelerated export from the <term sem="Cell_component" id="T52" lex="nucleus">nucleus</term> of <term sem="Cell_natural" id="T53" lex="activated_T_cell">activated <term sem="Cell_natural" id="T54" lex="T_cell">T cells</term></term>.</sentence>
<event id="E44">
<type class="Localization" />
<theme idref="T50" />
<clue>Strikingly, Western blotting and immunocytochemical experiments indicated that PDTC promoted a transient and rapid <clueType>shuttling</clueType> <linkTheme>of</linkTheme> NFATp and NFATc, leading to their accelerated export from the nucleus of activated T cells.</clue>
</event>
<event id="E45">
<type class="Localization" />
<theme idref="T51" />
<clue>Strikingly, Western blotting and immunocytochemical experiments indicated that PDTC promoted a transient and rapid <clueType>shuttling</clueType> <linkTheme>of</linkTheme> NFATp and NFATc, leading to their accelerated export from the nucleus of activated T cells.</clue>
</event>
<event id="E46">
<type class="Positive_regulation" />
<theme idref="E44" />
<cause idref="T49" />
<clue>Strikingly, Western blotting and immunocytochemical experiments indicated that PDTC <clueType>promoted</clueType> a transient and rapid shuttling of NFATp and NFATc, leading to their accelerated export from the nucleus of activated T cells.</clue>
</event>
<event id="E47">
<type class="Positive_regulation" />
<theme idref="E45" />
<cause idref="T49" />
<clue>Strikingly, Western blotting and immunocytochemical experiments indicated that PDTC <clueType>promoted</clueType> a transient and rapid shuttling of NFATp and NFATc, leading to their accelerated export from the nucleus of activated T cells.</clue>
</event>
<event id="E48">
<type class="Localization" />
<theme idref="T50" />
<clue>Strikingly, Western blotting and immunocytochemical experiments indicated that PDTC promoted a transient and rapid shuttling of NFATp and NFATc, leading to <corefTheme>their</corefTheme> accelerated <clueType>export</clueType> <clueLoc>from the nucleus of activated T cells</clueLoc>.</clue>
</event>
<event id="E49">
<type class="Localization" />
<theme idref="T51" />
<clue>Strikingly, Western blotting and immunocytochemical experiments indicated that PDTC promoted a transient and rapid shuttling of NFATp and NFATc, leading to <corefTheme>their</corefTheme> accelerated <clueType>export</clueType> <clueLoc>from the nucleus of activated T cells</clueLoc>.</clue>
</event>
<event id="E50">
<type class="Positive_regulation" />
<theme idref="E48" />
<cause idref="E46" />
<clue>Strikingly, <clueExperiment>Western blotting and immunocytochemical experiments</clueExperiment> indicated that PDTC promoted a transient and rapid shuttling of NFATp and NFATc, <clueType>leading to their accelerated</clueType> export from the nucleus of activated T cells.</clue>
</event>
<event id="E51">
<type class="Positive_regulation" />
<theme idref="E49" />
<cause idref="E47" />
<clue>Strikingly, <clueExperiment>Western blotting and immunocytochemical experiments</clueExperiment> indicated that PDTC promoted a transient and rapid shuttling of NFATp and NFATc, <clueType>leading to their accelerated</clueType> export from the nucleus of activated T cells.</clue>
</event>
<sentence id="S9">We propose that the activation of an <term sem="Protein_molecule" id="A5">NFAT kinase</term> by <term sem="Organic_compound_other" id="T55" lex="PDTC">PDTC</term> could be responsible for the rapid shuttling of the <term sem="Protein_family_or_group" id="T56" lex="NFAT">NFAT</term>, therefore transiently converting the sustained transactivation of this <term sem="Protein_family_or_group" id="T57" lex="transcription_factor">transcription factor</term> that occurs during <term sem="Other" id="T58" lex="lymphocyte_activation"><term sem="Cell_natural" id="A9">lymphocyte</term> activation</term>, and show that <term sem="Protein_molecule" id="T59" lex="c-Jun_NH2-terminal_kinase">c-Jun NH2-terminal kinase</term> (<term sem="Protein_molecule" id="T60" lex="JNK">JNK</term>) can act by directly phosphorylating <term sem="Protein_family_or_group" id="T61" lex="NFATp">NFATp</term>.</sentence>
<event id="E52">
<type class="Positive_regulation" />
<theme idref="A5" />
<cause idref="T55" />
<clue>We propose that the <clueType>activation</clueType> <linkTheme>of</linkTheme> an NFAT kinase <linkCause>by</linkCause> PDTC could be responsible for the rapid shuttling of the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event id="E53">
<type class="Localization" />
<theme idref="T56" />
<clue>We propose that the activation of an NFAT kinase by PDTC could be responsible for the rapid <clueType>shuttling</clueType> <linkTheme>of</linkTheme> the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event id="E54">
<type class="Positive_regulation" />
<theme idref="E53" />
<cause idref="E52" />
<clue>We propose that the activation of an NFAT kinase by PDTC could be <clueType>responsible</clueType> <linkTheme>for</linkTheme> the rapid shuttling of the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event id="E55">
<type class="Positive_regulation" />
<theme idref="T56" />
<cause idref="T56" />
<clue>We propose that the activation of an NFAT kinase by PDTC could be responsible for the rapid shuttling of the NFAT, therefore transiently converting the sustained <clueType>transactivation</clueType> <linkTheme>of</linkTheme> <corefTheme>this transcription factor</corefTheme> that occurs <clueTime>during lymphocyte activation</clueTime>, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event id="E56">
<type class="Positive_regulation" />
<theme idref="E55" />
<cause idref="E54" />
<clue>We propose that the activation of an NFAT kinase by PDTC could be <clueType>responsible</clueType> <linkTheme>for</linkTheme> the rapid shuttling of the NFAT, <linkCause>therefore</linkCause> transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event id="E57">
<type class="Physiological_process" />
<theme idref="A9" />
<clue>We propose that the activation of an NFAT kinase by PDTC could be responsible for the rapid shuttling of the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte <clueType>activation</clueType>, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event id="E58">
<type class="Protein_amino_acid_phosphorylation" />
<theme idref="T61" />
<cause idref="T60" />
<clue>We propose that the activation of an NFAT kinase by PDTC could be responsible for the rapid shuttling of the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c-Jun NH2-terminal kinase (JNK) can <clueType>act by directly phosphorylating</clueType> NFATp.</clue>
</event>
<sentence id="S10">In addition, the combined inhibitory effects on <term sem="Protein_family_or_group" id="T62" lex="NFAT">NFAT</term> and <term sem="Protein_complex" id="T63" lex="NF-KB">NF-KB</term> support a potential use of <term sem="Organic_compound_other" id="T64" lex="DTC">DTCs</term> as immunosuppressants.</sentence>
<event id="E59">
<type class="Negative_regulation" />
<theme idref="T62" />
<cause idref="T64" />
<clue>In addition, <corefCause>the</corefCause> combined <clueType>inhibitory effects</clueType> <linkTheme>on</linkTheme> NFAT and NF-KB support a potential use of DTCs as immunosuppressants.</clue>
</event>
<event id="E60">
<type class="Negative_regulation" />
<theme idref="T63" />
<cause idref="T64" />
<clue>In addition, <corefCause>the</corefCause> combined <clueType>inhibitory effects</clueType> <linkTheme>on</linkTheme> NFAT and NF-KB support a potential use of DTCs as immunosuppressants.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
